Related Experiment Videos
PET in breast cancer
F L Flanagan1, F Dehdashti, B A Siegel
1Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Seminars in Nuclear Medicine
|November 4, 1998
Summary
Positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) offers functional insights for breast cancer detection, staging, and treatment response assessment. This advanced imaging technique aids in evaluating tumor spread and predicting therapy effectiveness, potentially reducing the need for invasive procedures.
Area of Science:
- Oncology
- Radiology
- Nuclear Medicine
Background:
- Radiological evaluation of breast cancer has evolved with technological advancements.
- Current methods include mammography, ultrasonography, MRI, and functional imaging.
- Radiology is crucial for early detection, staging, prognosis, and treatment monitoring.
Purpose of the Study:
- To review the applications and limitations of positron emission tomography (PET) in breast cancer imaging.
- To highlight PET's role as a functional imaging modality.
- To discuss the utility of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG)-PET and 16 alpha-[18F]fluoro-17 beta-estradiol (FES)-PET.
Main Methods:
- Review of current literature on PET applications in breast cancer.
- Focus on FDG-PET for detection, discrimination, and staging.
- Discussion of FES-PET for monitoring hormonal therapy response.
Main Results:
- FDG-PET aids in detecting and characterizing primary breast cancer, especially in difficult cases.
- PET provides prognostic information by assessing tumor extent and nodal involvement.
- Serial FDG-PET can predict response to chemohormonotherapy.
- FES-PET offers insights into estrogen receptor status and hormonal therapy response.
Conclusions:
- FDG-PET is a valuable adjunct to anatomical imaging, providing functional information for breast cancer management.
- PET has the potential to improve staging accuracy and guide therapeutic decisions.
- Functional imaging with PET offers new avenues for personalized breast cancer treatment monitoring.